Drug Trial Radar · NCT06093672
Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera
Last checked: Nov 19, 2026Latest source record: Mar 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
220
Planned (sponsor's estimate)
Start
Mar 26, 2024
Primary completion
Jul 2026
Study completion Jul 2026
Sponsor
- Lead sponsor
- ItalfarmacoIndustry
- Sponsor type
- Industry
- Collaborators
- PPD Development, LP
- First posted
- Oct 23, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to compare the efficacy and safety of givinostat to hydroxyurea in Jak2V617F-positive high risk polycythemia vera patients.
Conditions
- Polycythemia Vera
Interventions
GivinostatDrug
Oral. The dosage must be modified, according to the manifestation of toxicities or lack of efficacy, with the aim to achieve an optimized dose.
HydroxyureaDrug
Oral. The dosage must be modified, according to the manifestation of toxicities or lack of efficacy, with the aim to achieve an optimized dose.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of patients achieving a response at Week 48.Time frame: week 25 - week 48
Locations
90 sites in 16 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama · Not yet recruiting
Emad Ibrahim, MD, Inc
Redlands, California · Recruiting
US Oncology Inc
Englewood, Colorado · Recruiting
American Oncology Partners of Maryland, PA
Bethesda, Maryland · Recruiting
Icahn School of Medicine at Mount Sinai
New York, New York · Recruiting
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina · Recruiting
The Cleveland Clinic Foundation
Cleveland, Ohio · Recruiting
Oncology Associates of Oregon, P.C.
Eugene, Oregon · Recruiting
MD Anderson Cancer Center
Houston, Texas · Recruiting
Texas Oncology (Webster) - USOR
Houston, Texas · Recruiting
Texas Oncology-Denison Cancer Center
Sherman, Texas · Recruiting
University of Utah - Huntsman Cancer Institute - PPDS
Salt Lake City, Utah · Recruiting
The James Cancer Hospital and Solove Research Institute
Roanoke, Virginia · Recruiting
VA Puget Sound Health Care System - NAVREF - PPDS
Seattle, Washington · Recruiting
Landesklinikum Wiener Neustadt
Wiener Neustadt, Lower Austria, Austria · Recruiting
Medizinische Universitat Wien (Medical University of Vienna)
Vienna, State of Vienna, Austria · Recruiting
Ordensklinikum Linz GmbH Elisabethinen
Linz, Upper Austria, Austria · Recruiting
Klinikum Wels-Grieskirchen GmbH
Wels, Upper Austria, Austria · Recruiting
University Multiprofile Hospital for Active Treatment Sveti Georgi EAD
Plovdiv, Bulgaria · Recruiting
University Multiprofile Hospital for Active Treatment - Prof. Dr. Stoyan Kirkovich AD
Stara Zagora, Bulgaria · Recruiting
Acibadem City Clinic Multiprofile Hospital for Active Treatment Tokuda
Sofia, Sofia-Grad, Bulgaria · Recruiting
Clinical Hospital Center Rijeka - PPDS
Rijeka, Croatia · Recruiting
Clinical Hospital Center Rijeka
Rijeka, Croatia · Not yet recruiting
General Hospital Sibenik
Šibenik, Croatia · Not yet recruiting
Clinical Hospital Dubrava
Zagreb, City of Zagreb, Croatia · Recruiting
Hôpital Saint Louis
Paris, France · Recruiting
Centre Hospitalier de Saint-Quentin
Saint-Quentin, Aisne, France · Recruiting
CHU de Nice
Nice, Alpes-Maritimes, France · Recruiting
Centre Hospitalier de Troyes
Troyes, Aube, France · Recruiting
Hopital d'Argenteuil
Argenteuil, Île-de-France Region, France · Recruiting
Hôpital Bretonneau
Tours, Indre-et-Loire, France · Recruiting
CHU Nantes
Nantes, Loire-Atlantique, France · Recruiting
CHU Angers
Angers, Maine-et-Loire, France · Recruiting
CHU Amiens Hôpital Sud
Amiens, Somme, France · Recruiting
OncoResearch Lerchenfeld GmbH
Hamburg, Germany · Recruiting
Medizinische Fakultät Mannheim der Universität Heidelberg, Universitätsmedizin Mannheim
Mannheim, Baden-Wurttemberg, Germany · Recruiting
Gemeinschaftspraxis Hämatologie - Onkologie
Dresden, Saxony, Germany · Recruiting
Universitätsmedizin Halle, Universitätsklinikum Halle, Klinik für Innere Medizin IV
Halle, Saxony-Anhalt, Germany · Withdrawn
Gyor-Moson-Sopron Vármegyei Petz Aladár Egyetemi Oktató Kórház
Győr, Győr-Moson-Sopron, Hungary · Recruiting
Szabolcs-Szatmár-Bereg Vármegyei Oktatókórház
Nyíregyháza, Szabolcs-Szatmár-Bereg, Hungary · Recruiting
Showing 40 of 90 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.